Search

Issue
Title
Authors
The effect of extended release metformin on MRI parameters of left ventricular remodeling in patients with prediabetes and heart failure with preserved ejection fraction
Tsygankova O.V., Apartseva N.E., Latyntseva L.D., Nikitin N.A.
Differential diagnosis of amiodarone-induced thyrotoxicosis in a patient with atrial fibrillation and agranulocytosis on the background of thyrostatic therapy. Case report
Zherebchikova K.Y., Bubnov D.S., Ermolaeva A.S., Soltakhanova M.O., Sych Y.P., Ezhov M.V., Fadeev V.V.
Differentsial'naya diagnostika otekov nizhnikh konechnostey v terapevticheskoy praktike i lechenie otechnogo sindroma pri khronicheskoy venoznoy nedostatochnosti
Zolotukhin I.A.
The arsenal of therapist: torasemide
Kirichenko A.A.
Management of a patient with dyspnea on an outpatient admission
Vertkin A.L., Topolyansky A.V., Knorring G.Y., Shamuilova M.M.
Decreased cardiac mortality with nicorandil in patients with ischemic heart failure
Yoshihisa A., Sato Y., Watanabe S., Yokokawa T., Sato T., Suzuki S., Oikawa M., Kobayashi A., Takeishi Y.
Sodium-glucose cotransporter 2 inhibitors: mechanisms of cardiorenal protection: A review
Leonova M.V.
Difference of genetic polymorphisms in patients with type 2 diabetes mellitus with absence or presence of chronic heart failure with preserved ejection fraction
Sveklina T.S., Shustov S.B., Kolyubaeva S.N., Kuchmin A.N., Kozlov V.A., Halimov Y.S., Konyaev V.V.
Pentraxin-3 – a promising biological marker in heart failure: literature review
Alieva A.M., Teplova N.V., Batov M.A., Voronkova K.V., Valiev R.K., Shnakhova L.M., Pinchuk T.V., Rakhaev A.M., Kalova M.R., Nikitin I.G.
The relevance of prescribing triple neurohormonal blockade in real clinical practice: the role of mineralocorticoid receptor antagonists
Zhirov I.V.
Fractalkin and cardiovascular disease
Alieva A.M., Almazova I.I., Pinchuk T.V., Reznik E.V., Rakhaev A.M., Nikitin I.G.
TORASEMIDE - THE DRUG FOR THE TREATMENT OF HEART FAILURE AND ARTERIAL HYPERTENSION
Trukhan D.I., Davydov E.L.
Trimetazidine (review of the latest foreign publications)
Akatova E.V.
Captopril in cardiovascular disease management
Terpigorev S.A., Nikishenkov A.M., Kabanova T.G., Zadionchenko V.S., Yalymov A.A., Shekhyan G.G., Shchikota A.M., Ivanova N.A., Bogatyrova K.M.
Principles of drug therapy of arterial hypertension
Zadionchenko V.S., Shekhyan G.G., Yalymov A.A., Shchikota A.M.
Angiotensin II receptor antagonist - candesartan in the arsenal of therapist
Kirichenko A.A.
Key features of candesartan application in clinical practice
Evdokimova A.G., Lozhkina M.V., Kovalenko E.V.
Miokardial'nyy tsitoprotektor trimetazidin MV kak vazhnyy komponent kompleksnoy terapii ishemicheskoy bolezni serdtsa i khronicheskoy serdechnoy nedostatochnosti
Trukhan D.I.
Klinicheskie i farmakoekonomicheskie aspekty terapii serdechnoy nedostatochnosti selektivnym antagonistom al'dosterona eplerenonom
Rudakova A.V., Moiseeva O.M.
Effektivnost' primeneniya ingibitorov angiotenzinprevrashchayushchego fermenta pri khronicheskoy serdechnoy nedostatochnosti
Evdokimov V.V., Evdokimova A.G.
Est' li mesto b-adrenoblokatoram u bol'nykh s metabolicheskim sindromom i khronicheskoy serdechnoy nedostatochnost'yu?
Drapkina O.M., Korneeva O.N., Tyurina E.V.
Sushchestvuyut li razlichiya v klinicheskoy effektivnosti metoprolola?
Ostroumova O.D., Smolyarchuk E.A., Rykova A.M., Zhbyr' L.M., Polikarpov V.A.
Osobennosti lecheniya khronicheskoy serdechnoy nedostatochnosti u bol'nykh arterial'noy gipertenziey
Preobrazhenskiy D.V., Stolyarova I.I., Sidorenko B.A., Sharoshina A.I., Stetsenko T.M.
The course of chronic heart failure, depending on patients’ body composition
Shevtsova V.I., Pashkova A.A., Petrenko A.R., Shevtsov A.N.
A clinical case of hereditary transthyretin amyloidosis. Case report
Shoshina A.A., Nasonova S.N., Zhirov I.V., Saidova M.A., Ansheles A.A., Meshkov A.N., Tereshchenko S.N.
Rational drug therapy of chronic heart failure: the role of mineralocorticoid receptor antagonists: review
Safronova N.V., Zhirov I.V., Tereshchenko S.N.
Age aspects of acute myocardial infarction
Khorolets E.V., Shlyk S.V., Bychkova O.I.
Cardiology 2020. The patient with chronic heart failure: a new trajectory of life
Hyperuricemia and chronic heart failure: risk factors and prognostic parallels
Larina V.N., Larin V.G.
PREVENTION AND OVERCOMING OF CARDIOTOXIC EFFECT OF CANCER THERAPY. INTERVIEW
Captopril effectiveness in treatment of patients with congestive heart failure and cardiopulmonary pathology
Evdokimov V.V., Evdokimova A.G., Kovalenko E.V., Tereshchenko O.I.
Angiotensin receptor blockers II in the treatment of arterial hypertension in patients with comorbid pathology: the possibilities of candesartan
Trukhan D.L., Davydov E.L.
Clinical aspects of application of candesartan
Rybachkova Y.V.
The characteristics of torasemide application in patients with arterial hypertension and chronic heart failure
Evdokimov V.V., Evdokimova A.G., Lozhkina M.V., Tebloev K.I.
Khronicheskaya serdechnaya nedostatochnost' u patsientov pozhilogo i starcheskogo vozrasta
Kirichenko A.A.
Koronarnaya angioplastika i stentirovanie u bol'nykh ishemicheskoy kardiomiopatiey (klinicheskiy sluchay)
Samko A.N., Merkulov E.V., Mironov V.M., Filatov D.N.
Vliyanie antiaritmicheskoy terapii na techenie khronicheskoy serdechnoy nedostatochnosti u patsientov s fibrillyatsiey predserdiy
Miller O.N., Tarasov A.V., Dik I.S., Doshchitsin V.L., Kramynina O.A., Pozdnyakov Y.M., Chuvashov A.S., Belyaeva I.E.
Metabolicheskaya terapiya mel'doniem: vozmozhnosti primeneniya v lechenii khronicheskoy serdechnoy nedostatochnosti u bol'nykh s metabolicheskim sindromom
Statsenko M.E., Turkina S.V., Evtereva E.D.
Evropeyskie rekomendatsii po diagnostike i lecheniyu khronicheskoy serdechnoy nedostatochnosti 2005 g.: chto novogo v voprosakh farmakoterapii?
Lopatin Y.M.
Fibroblast growth factor 21 (FGF21): diagnostic, prognostic and therapeutic aspects in heart failure. A review
Alieva A.M., Teplova N.V., Reznik E.V., Baykova I.E., Khadzhieva N.K., Voronkova K.V., Kovtiukh I.V., Valiev R.K., Kotikova I.A., Nikitin I.G.
Endocan is a key player in cardiovascular disease: A review
Alieva A.M., Reznik E.V., Baykova I.E., Teplova N.V., Makeeva L.M., Voronkova K.V., Khadzhieva N.K., Modestova A.V., Totolyan G.G., Valiev R.K., Li A.M., Kotikova I.A., Nikitin I.G.
Chronic heart failure – modification of treatment paradigm
Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
Efficacy and safety of long-term use of prolonged bronchodilators in patients with cardiopulmonary pathology and chronic heart failure
Evdokimov V.V., Yushchuk E.N., Evdokimova A.G., Stryuk R.I.
Reducing the risk of chronic heart failure development in patients with arterial hypertension from the position of evidence medicine (focus on candesartan)
Evdokimova A.G., Stryuk R.I., Evdokimov V.V., Golikova A.A.
Management of patients with chronic heart failure and diabetes mellitus from the standpoint of modern recommendations and in real clinical practice
Reznik E.V., Lazarev V.A., Kalova M.R., Nikitin I.G.
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: A CHOICE OF THE DRUG IN CLINICAL PRACTICE GIVEN THE EFFECTIVENESS AND SAFETY OF USE
Mubarakshina O.A., Liubavskaia S.S., Somova M.N., Batishcheva G.A.
The place of antagonists of mineralocorticoid receptors in the treatment of chronic heart failure
Orlova N.V., Spiryakina Y.G.
Asthma and cardiovascular disease
Ostroumova O.D., Goloborodova I.V., Voevodina N.Y., Fomina V.M., Seregin A.A.
Modern possibilities of torasemide application in clinical practice
Batishcheva G.A., Mubarakshina O.A., Somova M.N., Evstigneeva A.S.
Mineralocorticoid receptor antagonists: a dubious past and advanced future
Napalkov D.A.
Klinicheskaya effektivnost' antagonistov mineralokortikoidnykh retseptorov v lechenii bol'nykh s khronicheskoy serdechnoy nedostatochnost'yu
Berns S.A., Zverev K.V., Myasnikov A.L.
Organoprotektornye i metabolicheskie effekty taurina pri terapii bol'nykh s khronicheskoy serdechnoy nedostatochnost'yu i sakharnym diabetom tipa 2
Statsenko M.E., Shilina N.N., Vinnikova A.A.
Vliyanie ingibitorov angiotenzinprevrashchayushchego fermenta na funktsiyu pochek u bol'nykh arterial'noy gipertenziey starshikh vozrastnykh grupp
Mikheeva O.M., Komissarenko I.A., Levchenko S.V.
Kommentariy ekspertov Serdechnaya nedostatochnost' i narusheniya ritma serdtsa: taktika vedeniya
Arutyunov G.P.
Nitraty pri ishemicheskoy bolezni serdtsa v zavisimosti ot klinicheskoy formy i tyazhesti zabolevaniya
Lupanov V.P.
Gipertroficheskaya kardiomiopatiya: sovremennoe sostoyanie problemy (po materialam soobshcheniya Mezhdunarodnogo komiteta ekspertov po GKMP)
Gabrusenko S.A.
Study of the rs1800795 polymorphism of the IL6 gene to verify the clinical portrait of a patient with chronic heart failure: gender aspects
Khazovа E.V., Boulashova O.V., Valeeva E.V.
Modern aspects of diabetes mellitus type 2 treatment in cardiology practice (in the context of EASD/ADA consensus and Russian guidelines)
Evdokimova A.G., Golikova A.A., Striuk R.I., Lobanova E.G.
Sodium-glucose co-transporter-2 inhibitors in patients with heart failure. What's new? What are the prospects?
Erlikh A.D., Riabova D.V.
POSSIBILITIES OF PHARMACEUTICAL TREATMENT OF CARDIOGENIC ENCEPHALOPATHY WITH THE USE OF RUSSIAN MEDICATION WITH METABOLIC ACTION LEVOCARNITINE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CONGESTIVE HEART FAILURE
Mozheiko M.E., Bushueva E.V., Potanina M.V., Ryabikhin E.A.
Cognitive disorders in medical rehabilitation
Krasnov V.S., Shmonin A.A., Maltseva M.N., Melnikova E.V., Ivanova G.E.
Vybor effektivnogo diuretika dlya terapii khronicheskoy serdechnoy nedostatochnosti na ambulatornom etape: dovody v pol'zu torasemida
Larina V.N.
Correction of late violations of atrioventricular conduction in patients with lower myocardial infarction: the case of ivabradin
Loukianova I.Y., Shishkin A.N.
The mineralocorticoid receptor blockers in the treatment of chronic heart failure
Kirichenko A.A.
Non-compact myocardium of the left ventricle: secondary prevention of thromboembolic complications
Myasnikov R.P., Kulikova O.V., Kharlap M.S., Koretskiy S.N., Andreenko E.Y., Mershina E.A., Sinitsyn V.E., Boytsov S.A.
The application of calcium channel blockers in patients with cardiovascular disease: focus on the diltiazem
Zadionchenko V.S., Shehyan G.G., Yalymov A.A., Schikota A.M., Sherstyannikova O.M., Asymbekova E.U.
Effektivnost' primeneniya IAPF u bol'nykh s IBS i AG, osnovannaya na printsipakh dokazatel'noy meditsiny (fokus na zofenopril)
Evdokimova A.G., Evdokimov V.V., Smetanin A.V., Kozhina N.A.
Vozmozhnosti ingibitorov angiotenzinprevrashchayushchego fermenta v klinicheskoy praktike: fokus na fozinopril
Nebieridze D.V.
Opyt primeneniya trimetazidina u bol'nykhso stenokardiey i khronicheskoy serdechnoy nedostatochnost'yu
Nikitin A.V., Gosteva E.V., Vasil'eva L.V.
Primenenie petlevykh diuretikov u bol'nykh s kompensirovannoy khronicheskoy serdechnoy nedostatochnost'yu i vysokim davleniem napolneniya levogo zheludochka
Ovchinnikov A.G., Azizova A.G., Ageev F.T., Kuzmina A.E.
Sovremennye podkhody k lecheniyu patsientov s legochnoy gipertenziey v svete rekomendatsiy Evropeyskogo Obshchestva kardiologov
Martynyuk T.V., Nakonechnikov S.N., Chazova I.E.
Farmakoterapiya v kardiologii: pozitsii antagonistov kal'tsiya
Karpov Y.A., Sorokin E.V.
Comorbid conditions in patients with chronic heart failure (according to the registry of chronic heart failure in the Tyumen region)
Airapetian A.A., Lazareva N.V., Reitblat O.M., Mezhonov E.M., Evgeny E.V., Prints Y.S., Zhirov I.V., Tereshchenko S.N., Boytsov S.A.
Heart failure as a complication of myocardial infarction: rational therapy. Case report
Zhirov I.V., Safronova N.V., Tereshchenko S.N.
Captopril in cardiological patients treatment: is there still place for the “first of the Mohicans”?
Valikulova F.Y., Koroleva L.Y., Melnichenko O.V., Duryndina E.M., Muradova F.N., Alekseeva M.M.
Ventricular arrhythmias in chronic heart failure: features of treatment and the possibility of improving the prognosis
Bunin Y.A., Zolozova E.A.
Heart failure and contrast-induced acute kidney injury in patients with coronary artery disease
Mironova O.I., Sivakova O.A., Deev A.D., Fomin V.V.
CARDIOTOXICITY OF NON-STEROID ANTI-INFLAMMATORY DRUGS
Leonova M.V.
Cystatin C allows to detect early progression of chronic kidney disease in patients with acute decompensation of chronic heart failure
Davydov V.V., Arechina E.L.
Edema pharmacotherapy in patients with hepatic cirrhosis and congestive heart failure: loop diuretics in focus
Ketova G.G., Popov A.Y., Babich A.E., Luchinina E.V.
The role of antagonists of mineralocorticoid receptors in the pharmacotherapy of chronic heart failure
Batishcheva G.A., Mubarakshina O.A., Somova M.N., Dronova Y.M.
Pathogenetic substantiation inclusion of taurine in the treatment of patients with diabetes mellitus type 2
Statsenko M.E., Turkina S.V., Tyshchenko I.A., Gorbacheva E.E.
The characteristics of torasemide - loop diuretic application in patients with compensated heart failure
Ovchinnikov A.G.
Rol' trimetazidina kak energeticheskogo modulyatora v regulyatsii metabolizma miokarda pri ishemicheskoy bolezni serdtsa
Dorofeeva G.B., Dorofeev I.V., Trofimova Y.V.
Znachenie populyatsionnykh issledovaniy stabil'noy stenokardii v opredelenii riska neblagopriyatnogo prognoza, svyazannogos osobennostyami techeniya zabolevaniya
Solyanik E.V., Eliseeva E.V., Gel'tser B.I., Efitsenko E.V.
Perspektivy ispol'zovaniya koenzima Q pri ateroskleroze i khronicheskoy serdechnoy nedostatochnosti
Lankin V.Z.
Kardiogennaya entsefalopatiya. Faktory riska i podkhody k terapii
Fonyakin A.V., Mashin V.V., Geraskina L.A., Mashin V.V.
Khronicheskaya serdechnaya nedostatochnost' u lits pozhilogo vozrasta: osobennosti etiopatogeneza i medikamentoznogo lecheniya
Preobrazhenskiy D.V., Sidorenko B.A., Tarykina E.V., Makhmutkhodzhaev S.A., Pavlova A.V.
Statiny pri lechenii sakharnogo diabeta tipa 2
Susekov A.V.
Molecular mechanisms of inflammation in the development of heart failure: A review
Buziashvili Y.I., Asymbekova E.U., Tugeeva E.F., Rakhimov A.Z., Shakhnazaryan L.S., Akildzhonov F.R.
Catestanin – a promising biological marker for heart failure: A review
Alieva A.M., Teplova N.V., Reznik E.V., Ettinger O.A., Faradzhov R.A., Khachirova E.A., Kovtiukh I.V., Kotikova I.A., Sysoeva D.A., Bigushev I.R., Nikitin I.G.
Antagonists of mineralocorticoid receptors in the treatment of patients with post-infarced heart failure: the role of eplerenon
Kashtalap V.V., Sedykh D.Y., Barbarash O.L.
Neopterin is a biomarker of chronic heart failure (review of modern literature)
Alieva A.M., Pinchuk T.V., Voronkova K.V., Shnakhova L.M., Ettinger O.A., Akhmedova M.F., Valiev R.K., Kalova M.R., Gasanova E.T., Nikitin I.G.
P2-ADRENERGIC RECEPTORS GENETIC POLYMORPHISM, CARDIOVASCULAR DISORDERS AND INFLUENCE OF P-BLOCKERS’ EFFECTIVENESS
Leonova M.V.
Anxiety and depressive disorders in cardiology practice. Possibilities of using D,L-Hopantenic acid
Ostroumova O.D., Goloborodova I.V., Fomina V.M., Bondarets O.V.
Chronic obstructive pulmonary disease and comorbid cardiovascular disease: in the context of guidelines
Ostroumova O.D., Kochetkov A.I.
Treatment of chronic heart failure and arterial hypertension: two aims and one drug - torasemide
Trukhan D.I.
Possibilities of perindopril and ivabradin in patients with hypertensive disease in the normalization of hemodynamics, myocardial dysfunction and vascular endothelium
Ivanova O.F., Lebedev P.A., Vvedenskaya I.P., Komarova M.V., Paranina E.V.
Rezistin i diabeticheskaya kardiomiopatiya: patogeneticheskie vzaimosvyazi
Aleksandrov A.A., Shatskaya O.A., Kukharenko S.S., Yadrikhinskaya M.N., Abdalkina E.N., Drozdova E.N., Shestakova M.V.
Medikamentoznoe lechenie fibrillyatsii predserdiy. Sovremennoe sostoyanie problemy
Doshchitsin V.L.
1 - 100 of 139 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"